Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study-Reference-Cited by-同舟云学术

Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study

Published:2021-08 Issue:4 Volume:6 Page:100226
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Davie A.,Cuyun Carter G.,Rider A.,Bailey A.,Lewis K.,Price G.,Ostojic H.,Ringeisen F.,Pivot X.

Funder

Eli Lilly and Company

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference57 articles.

1. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome;Lobbezoo;Breast Cancer Res Treat,2013

2. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis;Solomayer;Breast Cancer Res Treat,2000

3. Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer – a retrospective analysis;Baur;Acta Med Austriaca,2001

4. Prognostic factors in 1,038 women with metastatic breast cancer;Largillier;Ann Oncol,2008

5. Long-term follow-up of patients with metastatic breast cancer: results of a retrospective, single-center analysis from 2000 to 2005;Geiger;Anticancer Drugs,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors;Frontiers in Oncology;2023-07-14

2. Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature Review;Targeted Oncology;2023-04-19

3. Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis;Cancers;2023-02-10